The iShares U.S. Consumer Staples ETF seeks to track the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, a benchmark composed of U.S. equities in the consumer staples sector. In practice, the fund provides diversified, market-cap-weighted access to producers of food, beverages, tobacco, and household and personal-care products, with a notable secondary allocation to healthcare distribution and retail names.
The portfolio's exposure is concentrated at the top. Procter & Gamble (PG) and Coca-Cola (KO) each represent roughly 13% of assets, followed by Philip Morris International (PM) near 11–12%. Other meaningful positions include PepsiCo (PEP), Altria Group (MO), McKesson (MCK), CVS Health (CVS), Mondelez International (MDLZ), Colgate-Palmolive (CL), and Monster Beverage (MNST). The top ten holdings together make up roughly two-thirds of the fund.
Sector-wise, food, beverage, and tobacco dominate at more than half of the portfolio, with household and personal products adding roughly a fifth. Healthcare distribution and retail contribute a smaller but growing slice, reflecting the fund's broader-than-typical "consumer goods" definition compared with more narrowly focused staples peers. The fund carries an expense ratio of about 0.38% and holds approximately 54–58 securities, a relatively compact basket that emphasizes large-cap, cash-generative businesses. This exposure profile gives the fund a low beta—historically around 0.3 to 0.5—and positions it as a lower-volatility, income-oriented sleeve within a broader equity allocation. I also checked this using Tickeron’s AI Screener to see how the holdings compare to others in the industry.
The macro environment is central to the fund's future outlook. Consumer staples are classic late-cycle and defensive performers: demand for everyday essentials stays relatively stable even when gross domestic product (GDP) growth softens, which can support relative outperformance during slowdowns or elevated volatility. Conversely, when the economy accelerates and risk appetite surges, staples often lag more cyclical segments of the market.
The interest-rate cycle is a defining variable. As lower-beta, dividend-paying assets, staples stocks frequently behave like "bond proxies," gaining appeal when yields fall and income-oriented investors search for stability. Sustained easing could provide a valuation tailwind, while persistently high yields would keep competitive pressure on the asset class.
Currency dynamics also matter. Several top holdings, including Coca-Cola and Philip Morris International, generate substantial revenue outside the United States, so a stronger dollar can weigh on translated earnings and reported growth. Finally, the sector's aggregate valuation—historically elevated relative to its own long-term averages at times—means that margin execution and volume stability, rather than multiple expansion alone, will need to anchor the sector outlook. From what I see, this interplay remains worth monitoring closely.
Over a longer horizon, several structural themes could shape the fund. Aging demographics in developed markets tend to support steady demand for healthcare-adjacent and essential consumer products, a mild tailwind for the fund's healthcare-distribution exposure. Global population growth and rising middle-class consumption in emerging markets continue to expand addressable demand for the multinational brand owners that dominate the portfolio, even as growth in developed markets matures.
At the same time, the shift toward health-and-wellness products and scrutiny of processed foods and tobacco represents both a risk and an opportunity. Companies that successfully reformulate portfolios, premiumize, and adapt to changing consumer preferences may sustain growth, while those exposed to regulatory pressure could face persistent headwinds. Market structure trends also favor large, brand-heavy staples firms with strong balance sheets, pricing power, and distribution scale.
The fund's structural tilt—low volatility, meaningful dividend income, and defensive cash flows—gives it a distinct role in diversified portfolios, particularly during periods of economic uncertainty or when interest rates are declining. However, its concentration in a handful of mega-cap names and its relatively modest number of holdings mean single-stock and regulatory risks warrant ongoing attention. As with any sector-specific vehicle, the long-term outlook will ultimately hinge on the interplay between pricing power, input costs, consumer demand, and the broader interest-rate cycle.
In my own research process, I often turn to Tickeron’s Trend Prediction Engine to review potential directional moves for holdings like those in IYK. The tool provides AI-driven forecasts that help put short-term trend signals in context alongside the fundamental drivers already discussed. It has been a practical addition when evaluating how macro shifts might translate into near-term price action for defensive names.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The Moving Average Convergence Divergence (MACD) for IYK turned positive on October 07, 2026. Looking at past instances where IYK's MACD turned positive, the stock continued to rise in 38 of 44 cases over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on IYK as a result. In 72 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
IYK moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Following a +1.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 232 of 299 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
The 10-day RSI Indicator for IYK moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 33 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 61 cases where IYK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows